Cell & Gene
Therapy CTDMO

Contract Testing, Development,
and Manufacturing Services for Advanced Therapies.

Connect with an expert

Delivering the Future
of Medicine

We are a global contract testing, development and manufacturing organization, (CTDMO). We enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world. Our vision is that one day, every drug can be made, and every disease can be treated.

Learn More About Us

Innovative and Transformative Services

For more than 20 years, we have been working with pioneers in advanced therapies to help them successfully discover, develop, manufacture and release their products for patient use.

Contract Testing

Proven analytical method development, lot release testing, viral clearance, stability, and more.

Learn More
WuXi Advanced Therapies_Testing Services
Process Development

Expert and flexible approaches to develop, scale, and optimize your processes and methods.

Learn More
WuXi Advanced Therapies_PD Home Page
IND Enabling Studies

Optimize processes, ensure GMP readiness, and secure data required for your IND submission.

Learn More
WuXi Advanced Therapies_successful IND submission
Clinical Manufacturing

Phase appropriate approaches that accelerate timelines and ensure quality clinical production.

Learn More
WuXi Advanced Therapies Plasmid Production
Commercial Manufacturing

High-quality, high-volume capacity, infrastructure, logistics, and systems which have passed inspection.

Learn More
WuXi Advanced Therapies Plasmid Manufacturing


Supply Chain

Modalities and Therapeutic Areas

Our experience and services cover CAR-T, T-Cell, TIL, MSC, AAV, Lenti, mAbs, Vaccines and other common advanced therapies.

Monoclonal Antibodies
Viral Vectors

Let's get started

Tell us about your program. Connect with experts.

Start Now

Articles & Events

Five Best Practices to Adapt and Improve Quality Control Programs for CGTs

To launch a successful GMP program for biologics, a robust quality control (QC) release testing protocol is essential. QC testing, which is mandated by global regulatory authorities, helps ensure that a product meets scientific specifications and reaches patients safely. Though each program will have unique parameters, QC testing should gather data to answer the following questions:

Jun 18
Boston, Massachusetts
Boston Immuno-Oncology Xchange 2024
Jun 25
Boston, Massachusetts
Boston Cell Therapy Manufacturing Xchange 2024
See All Events
Ameba Creative StudioAmeba Creative Studio